Literature DB >> 13137678

Mechanism of softening of tubercles. III. Hydrolysis of protein and nucleic acid during anaerobic autolysis of normal and tuberculous lung tissue in vitro.

C WEISS, J TABACHNICK, H P COHEN.   

Abstract

Entities:  

Keywords:  AUSCULTATION; NUCLEIC ACIDS; PROTEINS; TUBERCULOSIS, PULMONARY/pathology

Mesh：

Substances：

Year:  1954        PMID： 13137678

Source DB:  PubMed          Journal:  AMA Arch Pathol        ISSN： 0096-6711


× No keyword cloud information.
  7 in total

1.  Cellular death and necrosis: chemical, physical and morphologic changes in rat liver.

Authors:  G MAJNO; M LA GATTUTA; T E THOMPSON
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1960

2.  Tuberculosis induced by droplet nuclei infection; its developmental pattern in guinea pigs and rats in relation to dietary protein.

Authors:  H L RATCLIFFE; J V MERRICK
Journal:  Am J Pathol       Date:  1957 Nov-Dec       Impact factor: 4.307

3.  Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum.

Authors:  Jean-Philippe Lanoix; Thomas Ioerger; Aimee Ormond; Firat Kaya; James Sacchettini; Véronique Dartois; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

Review 4.  Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.

Authors:  Jansy P Sarathy; Véronique Dartois
Journal:  Clin Microbiol Rev       Date:  2020-04-01       Impact factor: 26.132

5.  Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis.

Authors:  Jean-Philippe Lanoix; Anne J Lenaerts; Eric L Nuermberger
Journal:  Dis Model Mech       Date:  2015-03-30       Impact factor: 5.758

Review 6.  Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses.

Authors:  Anne Lenaerts; Clifton E Barry; Véronique Dartois
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

7.  Impact of immunopathology on the antituberculous activity of pyrazinamide.

Authors:  Landry Blanc; Jansy Passiflora Sarathy; Nadine Alvarez Cabrera; Paul O'Brien; Isabela Dias-Freedman; Marizel Mina; James Sacchettini; Radojka M Savic; Martin Gengenbacher; Brendan K Podell; Brendan Prideaux; Thomas Ioerger; Thomas Dick; Véronique Dartois
Journal:  J Exp Med       Date:  2018-07-17       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.